“It’s a matter of days, not weeks,” Pfizer President and CEO Albert Boerla told ABC News on Sunday. Administration).
Currently, vaccines against COVID-19 Approved only for children 12 years of age and older, which is a cause of concern among health experts because cases in children begin in their school years and delta version, more permeable, spreads.
According to recent data published by the American Academy of Pediatrics, about 26% of all COVID-19 cases in the US are reported in children. According to the data on Sunday (26), an average of 266 children were hospitalized every day with Kovid-19 for the past one week. US Centers for Disease Control and Prevention (CDC).
Once the Pfizer/BioNtech data is available, they will have to go through two committees, one for the FDA and one for the CDC, the medical analyst said. CNN, Dr. Jonathan Rainer, No Domingo.
He said that if the data is sent this week, it will be in the committee by the end of October. And they have a lot of data to look at, he said.
“This is a vaccine for children, so getting the dosage right — in terms of efficacy and side effects — is important,” Rainer said.
But vaccinating children will be a difficult task even if a vaccine is available. According to one analysis, less than half of US teens are fully vaccinated against COVID-19 CNN of CDC data.
In response, officials need to do a better job of educating the public about the importance of vaccinations for the health of their children and families, Rainer said.
“If you want your kids in school, the best way to keep them there is to prevent them from getting COVID-19,” he said.
Until vaccines are approved for young children, the CDC recommends the use of masks for students, teachers and visitors in schools from kindergarten to grade 12, as well as tests based on improved ventilation, physical distancing, and screening. is recommended.
“We know how to keep them safe,” CDC Director Rochelle Valensky told CBS on Sunday. “When we don’t use proper mitigation, outbreaks are more likely to occur.”
normal life in a year
Borla also echoed the recent statement by the CEO of Moderna Pharmaceuticals that it is It is possible to expect a return to normal life in about a year..
“I believe that within a year, we will be able to return to normal life,” Borla said in an ABC News interview.
He said, however, that this does not mean that the Kovid-19 variant will no longer exist or that new doses of the vaccine will not be needed.
“I think the most likely scenario is annual reversion, but we don’t know for sure. We need to wait to see the data”, he concluded.
(*With information from Madeline Holcombe, CNN)